| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 18 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 9 |
| NetGPI | no | yes: 0, no: 9 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0016020 | membrane | 2 | 1 |
| GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: E9AMK2
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_NRD_NRD_1 | 69 | 71 | PF00675 | 0.602 |
| CLV_PCSK_FUR_1 | 67 | 71 | PF00082 | 0.588 |
| CLV_PCSK_KEX2_1 | 69 | 71 | PF00082 | 0.602 |
| CLV_PCSK_PC7_1 | 65 | 71 | PF00082 | 0.602 |
| DOC_PP2B_LxvP_1 | 9 | 12 | PF13499 | 0.570 |
| LIG_14-3-3_CanoR_1 | 26 | 34 | PF00244 | 0.442 |
| LIG_14-3-3_CanoR_1 | 48 | 56 | PF00244 | 0.418 |
| LIG_Actin_WH2_2 | 32 | 50 | PF00022 | 0.325 |
| LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.645 |
| LIG_EH_1 | 60 | 64 | PF12763 | 0.390 |
| LIG_FHA_2 | 99 | 105 | PF00498 | 0.403 |
| LIG_LIR_Apic_2 | 55 | 59 | PF02991 | 0.386 |
| LIG_LIR_Gen_1 | 60 | 71 | PF02991 | 0.401 |
| LIG_LIR_Nem_3 | 50 | 56 | PF02991 | 0.411 |
| LIG_LIR_Nem_3 | 60 | 66 | PF02991 | 0.412 |
| LIG_LIR_Nem_3 | 95 | 100 | PF02991 | 0.365 |
| LIG_Pex14_2 | 76 | 80 | PF04695 | 0.406 |
| LIG_SH2_STAT5 | 100 | 103 | PF00017 | 0.357 |
| LIG_SH2_STAT5 | 53 | 56 | PF00017 | 0.402 |
| LIG_SH3_1 | 56 | 62 | PF00018 | 0.384 |
| LIG_SH3_3 | 56 | 62 | PF00018 | 0.384 |
| LIG_SH3_3 | 9 | 15 | PF00018 | 0.568 |
| LIG_TYR_ITIM | 42 | 47 | PF00017 | 0.410 |
| MOD_CK1_1 | 3 | 9 | PF00069 | 0.617 |
| MOD_CK2_1 | 98 | 104 | PF00069 | 0.366 |
| MOD_GlcNHglycan | 5 | 8 | PF01048 | 0.329 |
| MOD_N-GLC_1 | 17 | 22 | PF02516 | 0.375 |
| MOD_NEK2_1 | 16 | 21 | PF00069 | 0.627 |
| MOD_NEK2_1 | 25 | 30 | PF00069 | 0.566 |
| MOD_NEK2_1 | 47 | 52 | PF00069 | 0.374 |
| MOD_PKA_2 | 25 | 31 | PF00069 | 0.442 |
| MOD_PKA_2 | 47 | 53 | PF00069 | 0.461 |
| TRG_ENDOCYTIC_2 | 44 | 47 | PF00928 | 0.345 |
| TRG_ER_diArg_1 | 66 | 69 | PF00400 | 0.416 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0S4J8M9 | Bodo saltans | 66% | 100% |
| A0A1X0NMV9 | Trypanosomatidae | 84% | 100% |
| A0A3S5H6A4 | Leishmania donovani | 97% | 100% |
| A0A422NE39 | Trypanosoma rangeli | 84% | 100% |
| A4H5H8 | Leishmania braziliensis | 96% | 100% |
| A4HTR9 | Leishmania infantum | 97% | 100% |
| D0A978 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 81% | 67% |
| V5B330 | Trypanosoma cruzi | 83% | 100% |